KSKutay Saglam

Kutay Saglam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kutay Saglam has a total of 168 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes*

    by Nilay Danış, Hüseyin Döngelli, Tarkan Ünek, Aylin Bacakoğlu, İlKer Turan, Abdullah Zeki Karasu, Fulya Günşar, Elvan Işık, Muhsin Murat Harputluoglu, Kutay Sağlam, et al.

    Background/Aims: De novo malignancies are an important long-term complication following liver transplantation (LT), driven bychronic immunosuppression and extended post-transplant survival. Understanding patterns by tumor type, timing, and patient characteristics is essential for optimized surveillance. This study aimed to evaluate the clinical characteristics and temporal trends of de novoneoplasms in LT recipients.Materials and Methods: A total of 6943 adult LT recipients from 16 Turkish centers were evaluated between 1999 and 2023). Two hundred eight patients with 220 histologically confirmed de novo malignancies (excluding hepatocellular carcinoma) were included. Patientswho died within 30 days or developed cancer within 90 days post-LT were excluded. Incidence and mortality rates were assessed acrosspost-transplant intervals.Results: Non-skin solid (53.2%), dermatologic (28.6%), and hematologic (18.2%) cancers were predominant. Most malignancies (76.8%)occurred within 10 years post-LT. Early-onset (<10 years) malignancies were more common in living donor recipients (62.7%, P = .001)and associated with higher mortality (39.6% vs. 11.8%, P < .001). Recipients ≤60 years exhibited a higher incidence of hematologiccancers (23.9% vs. 12.6%, P = .03) and increased mortality (39.4% vs. 27.0%, P = .05). In subgroup analysis, tacrolimus use was stronglyassociated with cutaneous squamous cell carcinoma (P = .004). Peak incidence occurred 2-10 years post-LT (≈13-14 per 1000 recipients), with non-skin solid tumors being the most frequent.Conclusion: De novo malignancies remain a significant long-term risk after LT, with outcomes influenced by tumor type, age, immunosuppression, and timing of onset. Risk-adapted surveillance and tailored oncologic management, particularly dermatologic screeningin tacrolimus-treated patients and enhanced surveillance during the 2-10 year post-transplant period are recommended to improvelong-term survival.Cite this article as: Danış N, Döngelli H, Ünek T, et al. De novo malignancies after liver transplantation: A multicenter cohort studyof incidence, timing, and outcomes. Turk J Gastroenterol. Published online February 20, 2026. doi:10.5152/tjg.2026.25748.

  • Open Access

    Everolimus induced pneumonitis in a liver transplant patient: Dilemma in the discrimination of pneumonia

    by Kutay Sağlam, Adem Köse, Murat Yalçınsoy, Yaşar Bayındır, Sezai Yılmaz

    Everolimus is one of the immunosuppressive drugs used in solid organ transplantation. Many side effects have been described for these immunosuppressive drugs, similar to other drugs in this category. The purpose of this case presentation is to draw attention to drug-induced pneumonitis, which is a rare and life-threatening side effect of everolimus. A nineteen-year-old female patient who received liver transplantation for toxic hepatitis was admitted to our institute with cough and dyspnea. Everolimus had been started in conjunction with tacrolimus therapy 6 months prior to admission. Her chest imaging were consistent with pneumonitis. Markers of infection and cultures were all negative. After discontinuation of everolimus, symptoms and radiological findings resolved. The adverse effects of the drug should be kept in mind while investigating possible infectious agents in liver transplant recipients who are prone to opportunistic infections.


  • Open Access

    The coexistence of gastrointestinal stromal tumors and malignancies: Our 10-year results

    by Yavuz Selim Angın, Cengiz Ceylan, Kutay Sağlam, Cemalettin Aydın

    Objective: Gastrointestinal stromal tumor (GIST) is one of the most common mesenchymal tumors in the gastrointestinal system, occurring frequently after epithelial tumors. Although rare, secondary epithelial malignancies can be associated with GISTs. It was planned to conduct a retrospective cohort study evaluating the coexistence of GISTs with malignancies and their long-term outcomes through clinical and pathological findings. Material and Methods: Demographic and clinicopathological data of 69 patients who underwent surgery for GIST between January 2011 and November 2021 were retrieved from the patient database. Variables between the groups with only GIST and those with a secondary malignancy alongside GIST were analyzed using the Chi-square test and Mann-Whitney U test. Long-term survival analyses were conducted using the Kaplan-Meier test. A p-value of Results: Out of the 69 patients in our population, 40 (58%) were male, and the median age was 65 years (interquartile range= 56-75). GIST was the most commonly located in the stomach (59.4%), and nine (13%) patients had a secondary malignancy. Tumor size, smooth muscle antibody (SMA), and S100 antibody expression showed significant differences between the groups (p< 0.001, p= 0.015, p= 0.006). Shorter survival was observed in patients with GIST plus secondary malignancy (p= 0.005). Conclusion: The incidence of other intraabdominal malignancies occurring alongside GISTs is more common than have been previously thought. While the presence of a secondary malignancy does not impact the overall survival (OS) in GISTs, it was observed that survival is dependent on the primary malignancy. Patients diagnosed with GISTs require thorough investigation and close monitoring for secondary malignancies.


  • Open Access

    Outcomes of Resection Anastomosis versus Hartmann’s Procedure in Sigmoid Volvulus

    by Cengiz Ceylan, Hüseyin Kocaaslan, Necip Tolga Baran, Kutay Sağlam, Yavuz Angın, Cemalettin Aydın

    AIM: This study seeks to ascertain the comparative efficacy between the Hartmann procedure (HP) and resection anastomosis (RA), with or without concurrent fecal diversion, as surgical interventions for Sigmoid Volvulus (SV). The primary objective is to discern the procedure associated with a more favorable clinical outcome. MATERIAL AND METHOD: The study cohort comprised individuals who underwent surgical intervention for SV within the timeframe of 2010 to 2022 at our clinical facility. Demographic particulars encompassing gender and age, as well as comorbid conditions, ASA scores, procedural modalities, postoperative untoward events, and duration of inpatient care, were sourced from the patient database. Evaluation of postoperative complications, occurring within the 30-day window post-surgery, was undertaken in conformity with the Clavien Dindo (CD) classification schema. Statistical analyses encompassing the Mann Whitney U test and chi-square test were applied for data interpretation. Variables with p-values below 0.05 were deemed to possess statistical significance. RESULTS: The study encompassed a total of 125 patients, of whom 99 (79.2%) were male. Among these, 51 (40.8%) patients were allocated to the HP group, while 74 (59.2%) were assigned to the RA group. Concerning hospitalization duration, the median period was 8 (2-30) days in the HP group and 10 (3-35) days in the RA group (p=0.013). In accordance with the CD Classification, 68 (54.4%) patients encountered complications linked to the surgical procedure, with 11 (8.8%) patients experiencing procedure-associated mortality. Despite the observed statistically significant inter-group variance, it was discerned that HP exhibited a superior performance in terms of complications when compared to RA (p=0.048). CONCLUSION: Significantly reduced durations of hospitalization and fewer occurrences of postoperative complications were observed within the cohort undergoing the Hartmann's procedure. As a result, we advocate that clinicians consider prioritizing the implementation of Hartmann's procedure for patients undergoing surgical intervention for SV.


  • Open Access

    The role of C-reactive protein/albumin ratio and prognostic nutritional index in the diagnosis of complicated acute appendicitis

    by Akile Zengin, Yusuf Murat Bağ, Mehmet Zeki Öğüt, Kutay Sağlam

    Objective: C-reactive protein (CRP) levels increase and albumin levels decrease in patients with inflammation. CRP/albumin ratio (CAR) is a new inflammation-associated prognostic indicator. The prognostic nutritional index (PNI) was described as a simple and neutral indicator of adverse outcomes not only in chronic diseases but also in acute conditions. The aim of this study was to investigate the clinical significance of the CAR and PNI value in differentiating complicated acute appendicitis (AA). Material and Methods: We retrospectively examined the medical records of 187 patients with AA. Patients were divided into two groups according to pathological results [non-complicated (n= 161) and complicated (n= 26)]. Demographic, clinical, laboratory, and pathological data were examined and compared between the groups. Logistic regression analyses were performed to determine the independent predictors for complicated AA. Results: Median age of the study group was 32 (23-41) years, and most of the patients were males (n= 101, 54%). Patients in the complicated AA group were significantly older compared to the patients in the non-complicated AA group [38 (32-49.5) years vs. 30 (22-41) years, p= 0.002]. The complicated AA group had significantly higher CAR level compared to the non-complicated AA group (p= 0.001). The length of hospital stay was significantly longer in the complicated AA group compared to the non-complicated AA group [2.5 (2-4.25) days vs. 1 (1-2) days, p< 0.001]. Other variables (including PNI) did not significantly differ between the groups. In univariate logistic regression analysis, only age was found to be a significant variable (OR= 1.045, 95% CI= 1.016-10.74, p= 0.002), but in multiple variate logistic regression analysis, no variable was found to be significant in predicting complicated AA. Conclusion: We concluded that CAR and PNI value are not independent predictors of complicated AA.


  • Open Access

    First two cases of literature: Caustic sclerosing cholangitis due to percutaneous treatment of hydatid liver disease causing liver transplantation

    by Gokalp Okut, Kutay Saglam, Huseyin Kocaaslan, Cuneyt Kayaalp

    Echinococcus granulosus is predominantly found in the liver and can be effectively managed through antihelminthic therapy, surgical intervention, or interventional radiology. Percutaneous treatment (PT) has gained wide-spread popularity due to its minimally invasive nature. An integral step in surgical and PT procedures involves the utilization of protoscolicidal agents to eliminate the parasites. However, the administration of protoscolicidal agents carries the risk of inducing caustic sclerosing cholangitis (SC) if there is a communication between the cyst and the biliary tract. In this pio-neering study, we present two cases of caustic SC that occurred subsequent to PT for hydatid liver, necessitating further progression of the disease and ultimately leading to liver transplantation.


  • Open Access

    Relationship between HER2 and clinicopathological data in gastric adenocarcinomas

    by Cengiz Ceylan, Yavuz Selim Angin, Necip Tolga Baran, Hüseyin Kocaaslan, Emrah Cengiz, Omer Güngörür, Mehmet Güzel, Kutay Saglam, Cemalettin Aydin

    Background/Aim: The impact of human epidermal growth factor receptor 2 (HER2) overexpression on the surveillance of gastric cancer remains uncertain. Typically, HER2 status is assessed in both locally advanced and metastatic diseases, and targeted therapies are applied to cases with HER2-positive status. Our objective was to investigate the correlation between HER2 receptor status, clinicopathological characteristics, and prognosis in gastric cancers across all stages. Based on the results from this investigation, we aim to provide clinicians with insights into the clinicopathological conditions that warrant HER2 investigation. Methods: In this retrospective study, we conducted a comprehensive analysis of clinicopathological data from a cohort of 169 patients who underwent surgical treatment for gastric cancer between 2014 and 2022. The HER2 status was determined based on results from immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) techniques applied to gastric cancer pathology samples. Based on the HER2 positivity, the patients were classified into two distinct groups: (1) HER2-positive and (2) HER2-negative. The relationship between the clinicopathological variables, HER2 status, and overall survival (OS) was evaluated using chi-squared and Kaplan–Meier analyses. A statistical significance level of P <0.05 was applied to determine significant associations. Results: According to the IHC analyses performed in our study population, 33 among 169 patients were HER2-positive (19.53%). Statistically significant factors related to HER2 positivity, such as male gender (P=0.009), pathological stage, N category, lymphovascular invasion status ([LVI] P=0.046), and proximal tumor location (P=0.015) were observed. In addition, OS was 40.49 (6.21) months in HER2-positive gastric cancer patients and 57.43 (3.48) months in HER2-negative gastric cancers (P=0.045). Conclusion: Irrespective of the pathological stage, gastric cancer exhibited HER2 positivity at a ratio of 5:1. Among the clinicopathological findings, a significant correlation was observed between HER2 expression and gastric cancers characterized by aggressive features. Moreover, HER2 positivity was associated with an unfavorable prognosis in gastric cancer patients.


  • Open Access

    Gastrointestinal Sistemde Temel Semiyoloji

    by Eyyüp Taşdemir, Feridun Gürlek, Arda Yavuz, Kübra Akan, Sibel Akpınar Tekgündüz, Muammer Çelik, Suade Badak, Murat Kemahlı, Erhan Ergin, Uğur Gülöksüz, et al.

    Sindirim Sistemi Hastalıklarında Oral Bulgular Eyyüp TAŞDEMİR Gastroözofageal Reflü Hastalığı Feridun GÜRLEK Gardner Sendromu Arda YAVUZ Peutz-Jeghers Sendromu Kübra AKAN Hemorajik Hastalıklar Sibel AKPINAR TEKGÜNDÜZ AIDS Muammer ÇELİK Kollajen Doku Hastalıkları Suade Özlem BADAK Vitamin Eksiklikleri ve Malabsorbsiyonlar Murat KEMAHLI İnflamatuvar Barsak Hastalıkları Erhan ERGİN Kurşun Zehirlenmesi Uğur GÜLÖKSÜZ Plummer Vinson Sendromu Çınar YILDIRIM Halitozis Çınar YILDIRIM Disfaji Fatih KIVRAKOĞLU Odinofaji Nuran AY Globus Sensation-Boğazda Kitle Duygusu Hüseyin Samet KOCA Arzu OR KOCA Retrosternal Yanma (Heartburn) Işıl KİBAR AKILLI Kalp Dışı Göğüs Ağrısı Müge BİLGE Bulantı ve Kusmaya Yaklaşım Elif Tuğba TUNCEL İshal – Diyare Pınar ERGEN Konstipasyon Tedavi Sibel GÜRAY MUNGAN Dispepsi Sevil ÖZER SARI Meteorizm ve Aşırı Gaz Ülkü BULUT BATUR Aerofaji-Hava Yutma, Geğirme Mehmet Önder EKMEN Flatulans Mehmet KÖSTEK Akut ve Kronik GİS Kanamalar Bahar BEKTAN KANAT Hematokezya Halit Eyyüp MUNGAN Okült Kanamalar Saygın ALTINER Gaitada Gizli Kanama Nazif YALÇIN Özofajit ve Hiatus Hernisi/Mallory Weiss Sendromu Berrin YALINBAŞ KAYA Ersin AKGÖLLÜ Portal Hipertansiyona Bağlı Kanamalar Yavuz ÇAĞIR Hemorajik ve Erozif Gastrit Yonca YILMAZ ÜRÜN Malignitelere Bağlı GİS Kanamalar Rabia KÖKSAL Hemobilia ve Aortoenterik Fistüller Yusuf Murat BAĞ Vasküler Anomali ve Ektaziler Hatice KÖSTEK Alt GIS Kanama Yapan Nedenler Dursun Burak ÖZDEMİR Kilo Kaybına Neden Olan Psikiyatrik Bozukluklar Neslihan CANSEL Visseral Ağrılar ve Somatoparietal Ağrı Barış TÜRKER Akut Abdominal Ağrılı Hastaya Yaklaşım ve Fizik Muayene Kutay SAĞLAM Akut Apandisit Ahmet KARAYİĞİT Akut Kolesistit Hüsnü Çağrı GENÇ Akut Pankreatit Sanem KAYHAN Duodenum Ülseri Perforasyonu Ahmet Cem ESMER İnce Barsak Obstrüksiyonu Kutay SAĞLAM Akut Divertikülit Jale AYALOĞLU Akut Mezenter İskemisi ve Abdominal Aort Anevrizması Hilal KURTOĞLU GÜMÜŞEL Kadınlarda Genital Nedenli Karın Ağrıları Sümeyye ÇİÇEK Spontan Bakteriyel Peritonit Harun KÜÇÜK Toraks ve Pulmoner Kökenli Karın Ağrıları (Kardiyak Harici) Işıl KİBAR AKILLI Nörolojik Kökenli Karın Ağrıları Osman Bilge KAYA Metabolik Nedenlere Bağlı Karın Ağrıları Mustafa Gürkan HAYTAOĞLU Hematolojik Nedenlere Bağlı Karın Ağrıları Lale AYDIN KAYNAR Toksinlere Bağlı Karın Ağrısı Burçin UYGUN Enfeksiyonlara Bağlı Karın Ağrıları Özlem AYDIN Ailesel Akdeniz Ateşi Recep EVCEN Kronik Yineleyici Karın Ağrıları ve Kronik Devamlı Karın Ağrıları Salih CIRIK Kronik Epigastrik Ağrı Timur ORHANOĞLU Peptik Ülser Ağrısı ve Mide Kanseri Evren PEKER Akut ve Kronik Gastritler Gözde TÜRKEL Akut ve Kronik Mezenterik İskemiler Murat DEVECİ Sağ Üst Kadran Ağrıları Murat KESKİN Karın Sağ Alt Kadran Ağrıları Banu TAŞKIRAN TATAR Sol Üst Kadran Karın Ağrıları Rahmi ASLAN Sol Alt Kadran Ağrısı Ayşe KEFELİ Hipogastrium Ağrıları Ayşe Nilgün KUL GİS Endoskopik İnceleme ve GİS Endoskopi Endikasyonları Fatih COŞKUN Endoskopi Kontrendikasyonlar ve Komplikasyonları Bünyamin SARITAŞ ERCP (Endoskopik Retrograd Kolanjio-Pankreatografi) Fatma ERSEVEN Karın İnspeksiyonu Sabri Engin ALTINTOP Karın Palpasyonu Seval AKPINAR Karın Perküyonu (Perküsyon) Başak ÇAKIR GÜNEY Karın Oskültasyonu Mehmet ALPUA

  • Results of Intrahepatic Cholangiocarcinoma Resections: a Single-Center Analysis

    by Kutay Saglam, Yusuf Murat Bag, Zafer Bilen, Burak Isik, Cemalettin Aydin, Sezai Yilmaz

    Introduction Intrahepatic cholangiocarcinoma (ICC) is the second most common primary neoplasm of the liver after hepatocellular carcinoma (HCC). Although an underlying cause is not usually found, liver flukes, cirrhosis, primary sclerosing cholangitis, and viral hepatitis have been found to increase the risk in recent years. In this study, we aimed to present our experience on ICC and compare the outcomes of patients with a concomitant liver pathology and with incidentally detected ICC. Patients and Methods Thirty-three patients who underwent surgical resection for ICC were included in the study. Patients were divided into two groups, group one (with concomitant liver disease, n = 13) and group two (incidentally detected ICC, n = 18). Demographics, perioperative findings, pathological properties, recurrence rates, and survival rates were retrospectively analyzed and compared between the groups. Results The mean age of patients was 59.77 ± 9.81 years, of whom sixteen (51.6%) were males. Thirteen patients (41.9%) had concomitant liver disease, the most common being chronic hepatitis B infection. Eighteen patients (58.1%) had incidentally detected ICC. There were no significant differences between the groups except for follow-up time and recurrence rate. The recurrence rate was significantly higher in the incidentally detected ICC group (61.1% versus 7.7%, p = 0.003). Follow-up time was significantly higher in patients with concomitant liver disease (42 versus 17.5 months, p = 0.007). The mortality rate was higher in the incidentally detected ICC group (55.6 to 23.1%, p = 0.071) but the difference did not reach statistical significance. Conclusion Surgical resection in ICC patients with underlying liver disease is associated with better prognosis than in incidentally detected ICC patients. Incidental ICC may be a different tumor with different biology, hence the high recurrence rates.


  • Portal vein reconstruction with cryopreserved vascular grafts: A two‐edged sword

    by Kutay Saglam, Tevfik Tolga Sahin, Sertac Usta, Cemalettin Koc, Emrah Otan, Cuneyt Kayaalp, Cemalettin Aydin, Sezai Yilmaz

    Background: Portal vein anastomotic complications related to size discrepancy are important causes of morbidity and mortality in pediatric liver transplantation. Interposed vascular grafts in portal vein anastomosis can solve this problem. The aim of this study is to evaluate the results of pediatric liver transplantations performed using cryopreserved interposed vascular grafts between graft portal vein and superior mesenteric vein (SMV)‐splenic vein (SpV) confluence.Methods: Twenty‐nine pediatric patients received liver transplantation using cryopreserved venous grafts in our Liver Transplant Institute between 2013 and 2020 were included in this study. Demographic, clinical, and operative characteristics and postoperative follow‐up were analyzed.Results: Sixteen patients (55.2%) had portal hypoplasia and five patients (17.2%) had portal vein thrombosis. In total, six patients (20.6%) suffered portal vein thrombosis in the early postoperative period. Three patients (10.3%) experienced portal vein thrombosis in the late postoperative period. Late portal vein thrombosis rate was significantly higher in patients with early portal vein thrombosis (3/6 patients [50%] versus 0/23 patients [0%]; p = .034). Lack of portal flow was significantly higher in patients with both early (50% versus 0%; p = .002) and late portal vein thrombosis (66.7% versus 6.7%; p = .03).Conclusion: Preoperative portal vein thrombosis and insufficient flow are important factors affecting success of liver transplant in children. The use of interposed vein grafts in problematic portal anastomoses can overcome portal flow problems.